|
23 Jan 2023 |
Ubiquigent collaborates with University of Glasgow on translational structural biology to accelerate drug discovery within the (de)ubiquitylation field
|
|
20 Jan 2023 |
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata
|
|
18 Jan 2023 |
Longevity Biotech Gero Entered a Research Collaboration With Pfizer to Discover Potential Targets for Fibrotic Diseases
|
|
12 Jan 2023 |
Arbor Biotechnologies Announces Expanded Strategic Partnership with Vertex, Now Extending to Precision Gene Editing Using Reverse Transcriptase
|
|
11 Jan 2023 |
Pheno Therapeutics announces worldwide license from UCB to a novel program for neurodegenerative disease
|
|
11 Jan 2023 |
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets
|
|
11 Jan 2023 |
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
|
|
10 Jan 2023 |
BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development
|
|
10 Jan 2023 |
Neurocrine Biosciences and Voyager Therapeutics Enter Strategic Collaboration for Development and Commercialization of Voyager’s GBA1 Program and Other Next-Generation Gene Therapies for Neurological Diseases
|
|
10 Jan 2023 |
Kronos Bio Announces Discovery Collaboration with Genentech to Advance Novel Therapies Against Transcriptional Targets in Oncology
|
|
09 Jan 2023 |
ReCode Therapeutics Announces Strategic Collaboration with AskBio to Explore Single Vector Gene-Editing Platform
|
|
09 Jan 2023 |
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
|
|
09 Jan 2023 |
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
|
|
09 Jan 2023 |
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases
|
|
09 Jan 2023 |
AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline
|
|
07 Jan 2023 |
Fosun Pharma and Henlius Entered into an Exclusive License Agreement for Serplulimab in the US
|
|
06 Jan 2023 |
Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech
|
|
06 Jan 2023 |
Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies
|
|
04 Jan 2023 |
NorthStar Medical Radioisotopes and Inhibrx Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Candidates
|
|
04 Jan 2023 |
Belharra Therapeutics Announces Broad Collaboration with Genentech to Discover and Develop Novel Medicines Across Multiple Therapeutic Areas
|
|
04 Jan 2023 |
Biogen and Alcyone Therapeutics Announce License and Collaboration Agreement to Evaluate a Novel Device to Improve Patient Experience and Access to Neurological ASO Therapies
|
|
03 Jan 2023 |
Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies
|
|
02 Jan 2023 |
Alteogen Enters Into an Exclusive License Agreement to Develop and Commercialize Biosimilar Products Enabled by Alteogen’s Hybrozyme™ Technology
|
|
28 Dec 2022 |
PeptiDream Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Peptide Drug Conjugates
|
|
28 Dec 2022 |
PeptiDream Announces New Research and Collaboration Agreement with Lilly for the Discovery of Novel Peptide Drug Conjugates
|
